Archegos-Like Exposures: Computing Risk with Fabrizio Anfuso

Stress-Testing Counterparty Risk: Anfuso’s Framework BUCHAREST – May 22, 2024 – In the wake of the Archegos Capital Management collapse, the need for robust counterparty risk management has never been more critical. Fabrizio Anfuso, a senior technical specialist, along with Dimotrios Karyampas, developed a framework addressing the complexity of stress-testing exposure to tail events, offering … Read more

Optimal treatment of Imipenem and meropenem against bloodstream infections caused by the Citrobacter spp | BMC Infectious Diseases

Yao Y, Falgenhauer L, Falgenhauer J, Hauri AM, Heinmüller P, Domann E, Chakraborty T, Imirzalioglu C. Carbapenem-Resistant Citrobacter spp. As an emerging concern in the Hospital-Setting: results from a Genome-Based regional surveillance study. Front Cell Infect Microbiol. 2021;11:744431. https://doi.org/10.3389/fcimb.2021.744431 Article  CAS  PubMed  PubMed Central  Google Scholar  Doran TI. The role of Citrobacter in clinical disease … Read more